# CTCL Directed Therapy

> **NCT03116659** · EARLY_PHASE1 · UNKNOWN · sponsor: **James J. Peters Veterans Affairs Medical Center** · enrollment: 8 (estimated)

## Conditions studied

- Lymphoma, T-Cell, Cutaneous

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Imiquimod

## Key facts

- **NCT ID:** NCT03116659
- **Lead sponsor:** James J. Peters Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2019-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03116659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03116659, "CTCL Directed Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03116659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*